The vanguard has arrived in the Clinical Laboratory: Array-based karyotyping for prognostic markers in chronic lymphocytic leukemia

Journal of Molecular Diagnostics

Volumn 12, Issue 2, 2010, Pages 144-146

  Gunn, Shelly R ^a,b  

^a Combimatrix Molecular Diagnostics ^*  (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC LYMPHATIC LEUKEMIA; CLINICAL LABORATORY; DISEASE MARKER; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPING; NOTE; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

EID: 77649144588     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2010.090203     Document Type: Note

References (19)

1. Heim S, Mitleman F: A new approach to an old problem. Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells, ed 2. Edited by F Mitelman, S Heim. New York, John Wiley & Sons, Inc., 1995, pp 1-5
2. Tijo JH, Levan A: The chromosome number of man. Hereditas 1956, 42:1-6
3. Fröhling S, Dohner H: Chromosomal abnormalities in cancer. N Engl J Med 2008, 359:722-734
4. Glassman AB, Hayes KJ: The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2005, 158:88-91
5. Penault-Llorca F, Bilous M, Dowsett M, Hanna W, Osamura RY, Ruschoff J, van de Vijver M: Emerging technologies for assessing HER2 amplification. Am J Clin Pathol 2009, 132:539-548
6. Barr FG, Womer RB: Molecular diagnosis of Ewing family tumors. J Mol Diagn 2007, 9:437-440
7. Gunn SR, Hibbard MK, Ismail SH, Lowry-Nordberg M, Mellink CHM, Bahler D, Abruzzo L, Enriquez E, Gorre ME, Mohammed MS, Robetorye RS: Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia. Leukemia 2009, 23:1011-1017
8. Hagenkord JM, Chang CC: The rewards and challenges of array-based karyotyping for clinical oncology applications. Leukemia 2009, 23:829-833
9. Hagenkord JM, Monzon FA, Kash SF, Lilleberg S, Xie Q, Kant JA: Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays. J Mol Diagn 2010, 12:184-196
10. Gunn SR, Mohammed MS, Gorre ME, Cotter PD, Kim J, Bahler DW, Preobrashensky SN, Higgins RA, Bolla AR, Ismail SH, de Jong D, Eldering E, van Oers MHJ, Mellink CHM, Keating MJ, Schlette EJ, Abruzzo LV, Robetorye RS: Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia. J Mol Diagn 2008, 10:442-451
11. Schwaenen C, Nessling M, Wessendorf S, Salvi T, Radlwimmer B, Kestler HA, Haslinger C, Stilgenbauer S, Dohner H, Bentz M, Lichter P: Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 2004, 101:1039-1044
12. Sargent R, Jones D, Abruzzo LV, Yao H, Bonderover J, Cisneros M, Wierda WG, Keating MJ, Luthra R: Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia. J Mol Diagn 2009, 11:25-34
13. Patel A, Kang SH, Lennon PA, Li YF, Rao PN, Abruzzo L, Shaw C, Chinalut AC, Cheung SW: Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia. Am J Hematol 2008, 83:540-546
14. Yeh IT, Martin MA, Robetorye RS, Bolla AR, McCaskill, Shah R, Gorre ME, Mohammed MS, Gunn SR: Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event. Mod Pathol 2009, 22:1169-1175
15. Shanafelt TD, Geyer SM, Kay NE: Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 2004, 103:1202-1210
16. Gunn SR, Gorre ME, Mohammed MS, McCaskill C, Hibbard MK, Barry TS, Yeh IT: Validation of an array CGH test for HER2 status using tumor-targeted DNA extraction from formalin fixed tissue: comparison with fresh frozen tissue results. Cancer Res 2009, 24:835S
17. Maciejewski JP, Ghulam JM: Whole genome scanning as a cytogenetic tool in hematologic malignancies. Blood 2008, 112:965-974
18. Pinkel D, Albertson DG: Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005, 37:S11-S17
19. Zhao X, Li C, Paez G, Chin K, Janne PA, Chen TH, Girard L, Minna J, Christianni D, Leo C, Gray J, Sellars W, Myerson M: An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 2004, 64:3060-3071